FIELD: chemistry.
SUBSTANCE: used are films made of glycosaminoglycan conjugates with 4- or 5-aminosalicylic acids or alginate conjugates with 4- or 5-aminosalicylic acids or intermixed conjugates or mixed conjugates and at least one polymer chosen from group including carboxymethyl cellulose, glycosaminoglycan, alginate, gelatine, albumin with salicylate content not less than 50%. Specified mixtures are treated with 2-20% iron (III) chloride solution at room temperature within 1-5 minutes. Surface complex lowers water- and biological liquids solubility of the film.
EFFECT: prolonged of biomaterial activity is provided.
10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MODIFIED HYALURONIC ACID PREPARING | 2000 |
|
RU2191782C2 |
METHOD FOR PREPARING MODIFIED GLYCOSAMINOGLYCANS POSSESSING ANALGESIC PROPERTY | 2005 |
|
RU2283320C1 |
HYALURONIC ACID DERIVATIVES OF LOWERED BIODEGRADABILITY | 2007 |
|
RU2350625C2 |
CONJUGATE OF HYALURONIC ACID AND NOVOCAINE WITH AMPHOTERIC PROPERTIES | 2011 |
|
RU2473351C2 |
METHOD FOR PRODUCTION OF MODIFIED DERMATHANE SULFATE | 2005 |
|
RU2318830C2 |
EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
METHOD FOR PROTECTING ANASTOMOSIS AT INTESTINAL RESCTIONS | 2000 |
|
RU2192256C2 |
AQUEOUS COMPOSITION FOR INSTILLATION IN BLADDER | 2015 |
|
RU2586285C1 |
METHOD FOR PRODUCTION OF MODIFIED ARABINOGALACTAN | 2007 |
|
RU2359975C2 |
CROSS-LINKED COPOLYMERS BASED ON POLYCARBOXYLIC POLYMERS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS COMPRISING CROSS-LINKED COPOLYMERS | 1997 |
|
RU2194055C2 |
Authors
Dates
2009-01-20—Published
2007-03-28—Filed